Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010

Emerg Infect Dis. 2014 Sep;20(9):1452-63. doi: 10.3201/eid2009.131481.

Abstract

In Scotland, the 2009 outbreak of Bacillus anthracis infection among persons who inject drugs resulted in a 28% death rate. To compare nonsurvivors and survivors, we obtained data on 11 nonsurvivors and 16 survivors. Time from B. anthracis exposure to symptoms or hospitalization and skin and limb findings at presentation did not differ between nonsurvivors and survivors. Proportionately more nonsurvivors had histories of excessive alcohol use (p = 0.05) and required vasopressors and/or mechanical ventilation (p≤0.01 for each individually). Nonsurvivors also had higher sequential organ failure assessment scores (mean ± SEM) (7.3 ± 0.9 vs. 1.2 ± 0.4, p<0.0001). Antibacterial drug administration, surgery, and anthrax polyclonal immune globulin treatments did not differ between nonsurvivors and survivors. Of the 14 patients who required vasopressors during hospitalization, 11 died. Sequential organ failure assessment score or vasopressor requirement during hospitalization might identify patients with injectional anthrax for whom limited adjunctive therapies might be beneficial.

Publication types

  • Historical Article
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anthrax / diagnosis
  • Anthrax / drug therapy
  • Anthrax / epidemiology*
  • Anthrax / history
  • Anthrax / transmission*
  • Bacillus anthracis*
  • Disease Outbreaks
  • Drug Users*
  • History, 21st Century
  • Humans
  • Immune Sera / administration & dosage
  • Public Health Surveillance
  • Risk Factors
  • Scotland / epidemiology
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Immune Sera
  • Vasoconstrictor Agents